Leuprorelin intranasal - Archimedes/West Pharmaceutical Services
Alternative Names: leuprorelide intranasal - ArchimedesLatest Information Update: 18 Nov 2021
At a glance
- Originator Archimedes Pharma; West Pharmaceutical Services
- Developer Archimedes Pharma
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Endometriosis
Most Recent Events
- 05 Aug 2014 Archimedes Pharma has been acquired by ProStrakan
- 30 Apr 2007 Phase-II clinical trials in Endometriosis in the US(Intranasal)
- 28 May 2001 This product is available for licensing worldwide (http://www.westdrugdelivery.com)